METHYL 4-(4-(TRIFLUOROMETHYL)PHENOXY)BENZOATE, 90.0%, 5g

N-(3,5-bis((Triisopropylsilyl)oxy)phenyl)-3-hydroxy-2-nitrobenzamide, 95%, 100mg

2-Bromo-5-(methoxycarbonyl)benzoic acid, 97%, 1g

C-[1-(4-Chloro-phenyl)-cyclopentyl]-methylamine, 95.0%, 1g

(E)-9-(2-Nitrovinyl)anthracene, 95.0%, 25mg

(1S,2S,3R,4R)-3-(TERT-BUTOXYCARBONYLAMINO)BICYCLO[2.2.1]HEPT-5-ENE-2-CARBOXYLIC ACID, 95%, 25mg

2-(3-Cyanophenyl)benzimidazole, 1g

2-(5-ETHOXYPYRIDIN-2-YL)ACETIC ACID, 97.0%, 250mg

4-Amino-1-(1-Boc-piperidin-4-yl)-1H-pyrazole, 97.0%, 1g

1-(3-Hydroxy-2-methylphenyl)ethanone, 95.0%, 100mg

N-(2-ACETYLPHENYL)-4-METHYLPENTANAMIDE, 95.0%, 100mg

1-(2-Bromo-ethyl)-4-fluoro-benzene, 98.0%, 1g

2,5-Diphenyloxazole, approx. 99%, for scintillation, 100 g, plastic packaging.